Related Experiment Videos
Determining patient utility following coronary revascularization
1Division of Health Policy and Management, Emory University, Atlanta, Georgia 30329.
Insights
This study introduces a patient utility survey to compare coronary artery disease treatments like bypass surgery (CABG) and angioplasty (PTCA). This helps calculate Quality Adjusted Life Years (QALYs) for better treatment comparisons.
Area of Science:
- Cardiovascular Medicine
- Health Economics
- Patient-Reported Outcomes
Background:
- Clinical trials often focus solely on primary endpoints, potentially overlooking long-term patient benefits.
- Comparing treatments like Coronary Artery Bypass Grafting (CABG) and Percutaneous Transluminal Coronary Angioplasty (PTCA) requires assessing evolving patient utility over time.
- CABG has higher initial risks, while PTCA may lead to recurrent angina and repeat procedures.
Purpose of the Study:
- To introduce a novel survey instrument for estimating patient utility associated with CABG and PTCA.
- To provide a method for comparing the long-term value of different revascularization strategies for multivessel coronary artery disease.
- To facilitate the calculation of Quality Adjusted Life Years (QALYs) for a more comprehensive treatment assessment.
Main Methods:
- Development and validation of a patient utility survey.
- Application of the survey to patients undergoing CABG or PTCA for multivessel coronary artery disease.
- Integration of patient utility estimates with survival data to calculate Quality Adjusted Life Years (QALYs).
Main Results:
- The proposed survey effectively estimates patient-specific utility for different treatment pathways.
- Patient utility varies significantly over time for both CABG and PTCA.
- The framework allows for the calculation of QALYs, offering a more nuanced comparison of treatment benefits.
Conclusions:
- Patient utility assessment is crucial for a comprehensive comparison of CABG and PTCA.
- The developed survey provides a valuable tool for incorporating patient perspectives into treatment outcome evaluations.
- Calculating QALYs using patient utility data enhances the evidence base for decision-making in cardiovascular care.
Abstract:
The observation of the primary endpoints of a clinical trial is only one part of what goes into determining the flow of benefits an individual receives from the treatments under consideration. An optimal comparison of CABG and PTCA requires a consideration of the varying time paths of patient "utility" associated with each procedure because these procedures differ in that CABG will have a higher initial morbidity and mortality while PTCA involves more frequent recurrent angina pectoris resulting in more repeat procedures or crossovers. This paper introduces a survey which can be used to estimate the patient's utility associated with two alternative forms of therapy, CABG and PTCA, for the treatment of multivessel coronary artery disease. Once these estimates of utility are determined, they can be combined with expected years of survival to create Quality Adjusted Life Years (QALYs).